Area of research
Pharmacology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Pharmacogenetics and Drug Metabolism, Hormonal and reproductive studies, Sexual Differentiation and Disorders, and Pain Management and Opioid Use.
Expanding Role of Endogenous Biomarkers for Assessment of Transporter Activity in Drug Development: Current Applications and Future Horizon.
Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic Approach
Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability
S-warfarin limited sampling strategy with a population pharmacokinetic approach to estimate exposure and cytochrome P450 (CYP) 2C9 activity in healthy adults.
Midazolam Limited Sampling Strategy With a Population Pharmacokinetic Approach to Simultaneously Estimate Cytochrome P450 (CYP) 3A Constitutive, Inhibition, and Induction/Activation Conditions in Healthy Adults
Communicating with Patients' Families and Physicians About Prognosis and Goals of Care
Variability in Metabolism of Imipramine and Desipramine Using Urinary Excretion Data†
Clinical Application of Pharmacogenomics